Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance)
Journal article published in 2019 by
Kristie A. Blum 
,
Blum Ka,
Polley My,
Mei‐Yin Polley,
Sin‐Ho Jung,
Jung Sh,
Travis J. Dockter,
Dockter Tj,
Sarah Anderson,
Hsi Ed,
Eric D. Hsi,
Nina Wagner‐Johnston,
Beth Christian,
Jim Atkins,
Cheson Bd
and other authors.
,
Blum Ka,
Polley My,
Mei‐Yin Polley,
Sin‐Ho Jung,
Jung Sh,
Travis J. Dockter,
Dockter Tj,
Sarah Anderson,
Hsi Ed,
Eric D. Hsi,
Nina Wagner‐Johnston,
Beth Christian,
Jim Atkins,
Cheson Bd
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 